The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Includes thermostabilized Ebola vaccines
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)